Summary
This prediction ended on 24.06.22 with a price of €57.79. With a performance of -7.73%, the BUY prediction by Mori8 finished with a loss. Mori8 has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -4.544% | -4.544% | 82.234% | -28.137% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by Mori8 for this prediction
In the thread Bayer AG diskutieren
Buy Bayer AG
11:58 | UBS stuft BAYER AG auf 'Buy' | 334 |
09:10 | BARCLAYS stuft BAYER AG auf 'Overweight' | 397 |
Di | JPMORGAN stuft BAYER AG auf 'Overweight' | 802 |
Di | JEFFERIES stuft BAYER AG auf 'Buy' | 959 |
Di | BARCLAYS stuft BAYER AG auf 'Overweight'
09:10 | BARCLAYS stuft BAYER AG auf 'Overweight' | 397 |
Di | JPMORGAN stuft BAYER AG auf 'Overweight' | 802 |
Di | JEFFERIES stuft BAYER AG auf 'Buy' | 959 |
Di | BARCLAYS stuft BAYER AG auf 'Overweight'